Dr. Uddalak Majumdar, MD

Dr. Majumdar practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Majumdar's NPI, 1659669000, was assigned on July 19, 2011. Dr. Majumdar holds Ohio license 35.130365.

Dr. Majumdar's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Majumdar's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Majumdar is also affiliated with Hillcrest Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Majumdar to 3 more hospitals and 2 clinical labs, each named with a free account. Dr. Majumdar's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Majumdar practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Majumdar's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Majumdar's licenses on file in 2 states: Ohio and Illinois.

CMS data shows 514 Medicare services from Dr. Majumdar across 9 procedure codes in 2024, for 259 Medicare patients. Medicare paid $42,217 for them.

CMS counts 259 Medicare patients who saw Dr. Majumdar in 2024. The largest group is 65 to 74, with 110 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Majumdar's median patient age at 68, with 60% women.

In 2024, Dr. Majumdar wrote 767 Medicare Part D claims for 192 patients. CMS names the drug for 649 of them, across 22 drugs with 11 or more claims each, at $155,723 in total drug cost. In 2023, CMS named 157 claims across 7 drugs.

Dr. Majumdar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Majumdar as offering telehealth.

Dmand AI links 26 papers to Dr. Majumdar, published from 2011 to 2024. 2021 was the busiest year, with 6. The most frequent topics are Heart Defects, Congenital, Disease Models, Animal and Forced Expiratory Volume. Dr. Majumdar has published most often in Chest. Dr. Majumdar's most frequent co-authors are Vidu Garg, MD, Sanjay Ghosh, MD and Kim Lewis McBride, MD.

CMS Open Payments shows 14 general payments to Dr. Majumdar from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. AstraZeneca Pharmaceuticals LP paid the most, $189.